Charles Farkas

Charles Farkas

Director/Board Member at CONMED CORPORATION

Net worth: 774 021 $ as of 31/08/2026

74 year
Commercial Services
Consumer Services
Health Services

Profile

Mr. Charles M.
Farkas
is an Independent Director at CONMED Corp., a Chairman at Courtagen Life Sciences, Inc. and a Chairman at Medicinal Genomics Corp.
He is on the Board of Directors at CONMED Corp., Intuitive Health LLC, NOWDiagnostics, Inc., Sequel Youth & Family Services LLC, The John A. Hartford Foundation, Inc. and United Bridge Partners LP.
Mr. Farkas was previously employed as a Managing Director by Bain & Co. Canada, Inc. and a Senior Partner & Global Head-Healthcare Practice by Bain & Co., Inc. He also served on the board at Harvard Medical School.
He received his undergraduate degree from Princeton University and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
02/06/2026 15,527 ( 0.05% ) 774 021 $ 31/08/2026

Charles Farkas active positions

CompaniesPositionStart
CONMED CORPORATION Director/Board Member 23/07/2014
Director/Board Member -
Chairman -
Director/Board Member -
Chairman -
Director/Board Member -
Director/Board Member -
Director/Board Member -

Former positions of Charles Farkas

CompaniesPositionEnd
Director/Board Member 01/01/2017
░░░░ ░░░░░ ░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Charles Farkas's experience

Training of Charles Farkas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

79

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Electronic Technology

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Health Services

Consumer Services

Health Services

Industrial Services

Consumer Services

Health Services

  1. Stock Market
  2. Insiders
  3. Charles Farkas
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!